294 related articles for article (PubMed ID: 32916306)
1. Infusion of donor feces affects the gut-brain axis in humans with metabolic syndrome.
Hartstra AV; Schüppel V; Imangaliyev S; Schrantee A; Prodan A; Collard D; Levin E; Dallinga-Thie G; Ackermans MT; Winkelmeijer M; Havik SR; Metwaly A; Lagkouvardos I; Nier A; Bergheim I; Heikenwalder M; Dunkel A; Nederveen AJ; Liebisch G; Mancano G; Claus SP; Benítez-Páez A; la Fleur SE; Bergman JJ; Gerdes V; Sanz Y; Booij J; Kemper E; Groen AK; Serlie MJ; Haller D; Nieuwdorp M
Mol Metab; 2020 Dec; 42():101076. PubMed ID: 32916306
[TBL] [Abstract][Full Text] [Related]
2. Donor metabolic characteristics drive effects of faecal microbiota transplantation on recipient insulin sensitivity, energy expenditure and intestinal transit time.
de Groot P; Scheithauer T; Bakker GJ; Prodan A; Levin E; Khan MT; Herrema H; Ackermans M; Serlie MJM; de Brauw M; Levels JHM; Sales A; Gerdes VE; Ståhlman M; Schimmel AWM; Dallinga-Thie G; Bergman JJ; Holleman F; Hoekstra JBL; Groen A; Bäckhed F; Nieuwdorp M
Gut; 2020 Mar; 69(3):502-512. PubMed ID: 31147381
[TBL] [Abstract][Full Text] [Related]
3. Improvement of Insulin Sensitivity after Lean Donor Feces in Metabolic Syndrome Is Driven by Baseline Intestinal Microbiota Composition.
Kootte RS; Levin E; Salojärvi J; Smits LP; Hartstra AV; Udayappan SD; Hermes G; Bouter KE; Koopen AM; Holst JJ; Knop FK; Blaak EE; Zhao J; Smidt H; Harms AC; Hankemeijer T; Bergman JJGHM; Romijn HA; Schaap FG; Olde Damink SWM; Ackermans MT; Dallinga-Thie GM; Zoetendal E; de Vos WM; Serlie MJ; Stroes ESG; Groen AK; Nieuwdorp M
Cell Metab; 2017 Oct; 26(4):611-619.e6. PubMed ID: 28978426
[TBL] [Abstract][Full Text] [Related]
4. Effects of fecal microbiota transplant on DNA methylation in subjects with metabolic syndrome.
van der Vossen EWJ; Bastos D; Stols-Gonçalves D; de Goffau MC; Davids M; Pereira JPB; Li Yim AYF; Henneman P; Netea MG; de Vos WM; de Jonge W; Groen AK; Nieuwdorp M; Levin E
Gut Microbes; 2021; 13(1):1993513. PubMed ID: 34747338
[TBL] [Abstract][Full Text] [Related]
5. Recipient microbiome-related features predicting metabolic improvement following fecal microbiota transplantation in adults with severe obesity and metabolic syndrome: a secondary analysis of a phase 2 clinical trial.
Zhang Z; Mocanu V; Deehan EC; Hotte N; Zhu Y; Wei S; Kao DH; Karmali S; Birch DW; Walter J; Madsen KL
Gut Microbes; 2024; 16(1):2345134. PubMed ID: 38685731
[TBL] [Abstract][Full Text] [Related]
6. Effect of Vegan Fecal Microbiota Transplantation on Carnitine- and Choline-Derived Trimethylamine-N-Oxide Production and Vascular Inflammation in Patients With Metabolic Syndrome.
Smits LP; Kootte RS; Levin E; Prodan A; Fuentes S; Zoetendal EG; Wang Z; Levison BS; Cleophas MCP; Kemper EM; Dallinga-Thie GM; Groen AK; Joosten LAB; Netea MG; Stroes ESG; de Vos WM; Hazen SL; Nieuwdorp M
J Am Heart Assoc; 2018 Mar; 7(7):. PubMed ID: 29581220
[TBL] [Abstract][Full Text] [Related]
7. Gut bacteriophage dynamics during fecal microbial transplantation in subjects with metabolic syndrome.
Manrique P; Zhu Y; van der Oost J; Herrema H; Nieuwdorp M; de Vos WM; Young M
Gut Microbes; 2021; 13(1):1-15. PubMed ID: 33794724
[TBL] [Abstract][Full Text] [Related]
8. Serotonin Transporter Binding in the Diencephalon Is Reduced in Insulin-Resistant Obese Humans.
Versteeg RI; Koopman KE; Booij J; Ackermans MT; Unmehopa UA; Fliers E; la Fleur SE; Serlie MJ
Neuroendocrinology; 2017; 105(2):141-149. PubMed ID: 27626923
[TBL] [Abstract][Full Text] [Related]
9. Fecal microbiota transplantation improves metabolic syndrome parameters: systematic review with meta-analysis based on randomized clinical trials.
Proença IM; Allegretti JR; Bernardo WM; de Moura DTH; Ponte Neto AM; Matsubayashi CO; Flor MM; Kotinda APST; de Moura EGH
Nutr Res; 2020 Nov; 83():1-14. PubMed ID: 32987284
[TBL] [Abstract][Full Text] [Related]
10. Fecal microbial transplantation and fiber supplementation in patients with severe obesity and metabolic syndrome: a randomized double-blind, placebo-controlled phase 2 trial.
Mocanu V; Zhang Z; Deehan EC; Kao DH; Hotte N; Karmali S; Birch DW; Samarasinghe KK; Walter J; Madsen KL
Nat Med; 2021 Jul; 27(7):1272-1279. PubMed ID: 34226737
[TBL] [Abstract][Full Text] [Related]
11. Differential metabolic effects of oral butyrate treatment in lean versus metabolic syndrome subjects.
Bouter K; Bakker GJ; Levin E; Hartstra AV; Kootte RS; Udayappan SD; Katiraei S; Bahler L; Gilijamse PW; Tremaroli V; Stahlman M; Holleman F; van Riel NAW; Verberne HJ; Romijn JA; Dallinga-Thie GM; Serlie MJ; Ackermans MT; Kemper EM; Willems van Dijk K; Backhed F; Groen AK; Nieuwdorp M
Clin Transl Gastroenterol; 2018 May; 9(5):155. PubMed ID: 29799027
[TBL] [Abstract][Full Text] [Related]
12. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
Halmos T; Suba I
Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
[TBL] [Abstract][Full Text] [Related]
13. Fecal microbiota transplantation in metabolic syndrome: History, present and future.
de Groot PF; Frissen MN; de Clercq NC; Nieuwdorp M
Gut Microbes; 2017 May; 8(3):253-267. PubMed ID: 28609252
[TBL] [Abstract][Full Text] [Related]
14. Treating Obesity and Metabolic Syndrome with Fecal Microbiota Transplantation.
Marotz CA; Zarrinpar A
Yale J Biol Med; 2016 Sep; 89(3):383-388. PubMed ID: 27698622
[TBL] [Abstract][Full Text] [Related]
15. Fecal transplantation and butyrate improve neuropathic pain, modify immune cell profile, and gene expression in the PNS of obese mice.
Bonomo RR; Cook TM; Gavini CK; White CR; Jones JR; Bovo E; Zima AV; Brown IA; Dugas LR; Zakharian E; Aubert G; Alonzo F; Calcutt NA; Mansuy-Aubert V
Proc Natl Acad Sci U S A; 2020 Oct; 117(42):26482-26493. PubMed ID: 33020290
[TBL] [Abstract][Full Text] [Related]
16. Roux-en-Y gastric bypass surgery of morbidly obese patients induces swift and persistent changes of the individual gut microbiota.
Palleja A; Kashani A; Allin KH; Nielsen T; Zhang C; Li Y; Brach T; Liang S; Feng Q; Jørgensen NB; Bojsen-Møller KN; Dirksen C; Burgdorf KS; Holst JJ; Madsbad S; Wang J; Pedersen O; Hansen T; Arumugam M
Genome Med; 2016 Jun; 8(1):67. PubMed ID: 27306058
[TBL] [Abstract][Full Text] [Related]
17. Species- and strain-level assessment using
Benítez-Páez A; Hartstra AV; Nieuwdorp M; Sanz Y
Gut Microbes; 2022; 14(1):2078621. PubMed ID: 35604764
[TBL] [Abstract][Full Text] [Related]
18. Plasma Metabolites Related to Peripheral and Hepatic Insulin Sensitivity Are Not Directly Linked to Gut Microbiota Composition.
Koopen AM; de Clercq NC; Warmbrunn MV; Herrema H; Davids M; de Groot PF; Kootte RS; Bouter KEC; Nieuwdorp M; Groen AK; Prodan A
Nutrients; 2020 Jul; 12(8):. PubMed ID: 32752028
[TBL] [Abstract][Full Text] [Related]
19. Serotonin transporters in dopamine transporter imaging: a head-to-head comparison of dopamine transporter SPECT radioligands 123I-FP-CIT and 123I-PE2I.
Ziebell M; Holm-Hansen S; Thomsen G; Wagner A; Jensen P; Pinborg LH; Knudsen GM
J Nucl Med; 2010 Dec; 51(12):1885-91. PubMed ID: 21078806
[TBL] [Abstract][Full Text] [Related]
20. Modification of fecal microbiota as a mediator of effective weight loss and metabolic benefits following bariatric surgery.
Oduro-Donkor D; Turner MC; Farnaud S; Renshaw D; Kyrou I; Hanson P; Hattersley J; Weickert MO; Menon V; Randeva HS; Barber TM
Expert Rev Endocrinol Metab; 2020 Sep; 15(5):363-373. PubMed ID: 32840125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
